Format

Send to

Choose Destination
J Infect Dis. 2017 Dec 12;216(11):1329-1333. doi: 10.1093/infdis/jix484.

Clinical Usage of the Adjuvanted Herpes Zoster Subunit Vaccine (HZ/su): Revaccination of Recipients of Live Attenuated Zoster Vaccine and Coadministration With a Seasonal Influenza Vaccine.

Oxman MN1,2, Harbecke R1,3, Koelle DM4,5,6,7.

Author information

1
Department of Medicine, Division of Infectious Diseases, University of California, San Diego, La Jolla.
2
Medicine Service, Infectious Diseases Section, Veterans Affairs San Diego Healthcare System, California.
3
Research Service, Veterans Affairs San Diego Healthcare System, California.
4
Department of Medicine, Laboratory Medicine, University of Washington.
5
Department of Global Health, University of Washington.
6
Vaccine and Infectious Diseases Division, Fred Hutchinson Cancer Research Center.
7
Benaroya Research Institute, Seattle, Washington.

KEYWORDS:

adjuvant; glycoprotein E; influenza vaccine; re-vaccination; zoster vaccine

PMID:
29029303
PMCID:
PMC5853975
DOI:
10.1093/infdis/jix484
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Silverchair Information Systems Icon for PubMed Central
Loading ...
Support Center